Baird Small/Mid Cap Growth Fund
Fund
BSGSX
Price as of:
$14.82
+ $0.08
+ 0.54%
Primary Theme
fund company
Name
As of 04/22/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-5.9%
1 yr return
-3.5%
3 Yr Avg Return
-7.2%
5 Yr Avg Return
7.5%
Net Assets
$177 M
Holdings in Top 10
27.1%
52 WEEK LOW AND HIGH
$14.7
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.23%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 50.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$2,500
IRA
$1,000
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 04/22/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
BSGSX - Profile
Distributions
- YTD Total Return -5.9%
- 3 Yr Annualized Total Return -7.2%
- 5 Yr Annualized Total Return 7.5%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.88%
- Dividend Yield 0.0%
- Dividend Distribution Frequency None
Fund Details
-
Legal NameBaird Small/Mid Cap Growth Fund
-
Fund Family NameBaird
-
Inception DateOct 31, 2018
-
Shares Outstanding47675
-
Share ClassInvestor
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerJonathan Good
Fund Description
The Fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of U.S. and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts (“ADRs”) that are traded on major U.S. exchanges. Although the Fund principally invests in U.S. companies, the Fund may invest up to 15% of its total assets in equity securities (consisting of common stocks, ordinary shares and ADRs) of foreign companies. The Fund defines small- and mid-capitalization companies as those companies with a market capitalization within the range of companies in the Russell 2500® Growth Index at the time of investment.
When analyzing equity securities to be purchased by the Fund, the Advisor emphasizes a company’s growth prospects. The Fund’s investments are selected using a variety of both quantitative techniques and fundamental research in seeking to maximize the Fund’s expected return while controlling risk.
The Fund seeks a portfolio comprised of companies which reflect “PRIME” growth factors. These factors are analyzed as part of the Advisor’s investment process and are represented in the following ways:
•Durable Profitability. Companies with attractive margins and favorable margin trends can drive superior earnings growth.
•Sustainable Revenue Growth. Solid barriers to entry, favorable pricing and demonstrated product/service track records can aid top-line prospects.
•Favorable Industry dynamics.
•Management strength and integrity is a critical element of a high quality company. Growth, profitability and shareholder returns provide insight into management effectiveness. The Advisor seeks companies with management that position their company’s balance sheet to be a source of strength.
•Understanding market Expectations of a company is important in assessing risk/return opportunities.
The Advisor believes an analysis of these PRIME factors yields insights into the competitive strength of a business model.
The Advisor applies the following strategies when purchasing securities for the Fund’s portfolio:
•Typically holding the securities of fewer than 70 companies with exposure to approximately 20 industries.
•Seeking securities whose growth prospects, in the Advisor’s opinion, are not reflected in their current stock prices.
•Limiting the size of any one new position. No security will represent more than 5% of the Fund’s total assets at the time of purchase.
The Advisor may sell a security when the price meets or exceeds the Advisor’s targeted valuation or price range for the security, when a significant change occurs that adversely affects the Advisor’s premise or reasons for investing in the security or when the company experiences a fundamental deterioration in its business, financial condition or results, or growth prospects.
BSGSX - Performance
Return Ranking - Trailing
| Period | BSGSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -5.9% | -20.2% | 18.8% | 97.97% |
| 1 Yr | -3.5% | -10.9% | 46.0% | 99.44% |
| 3 Yr | -7.2%* | -29.8% | 78.1% | 84.00% |
| 5 Yr | 7.5%* | -5.4% | 97.1% | 69.45% |
| 10 Yr | N/A* | -0.4% | 35.9% | N/A |
* Annualized
Return Ranking - Calendar
| Period | BSGSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 10.6% | -27.7% | 68.0% | 85.71% |
| 2022 | -27.8% | -85.6% | 350.1% | 31.34% |
| 2021 | 14.3% | -77.0% | 238.3% | 13.05% |
| 2020 | 41.2% | -44.1% | 2474.5% | 19.84% |
| 2019 | 36.7% | -50.2% | 44.0% | 6.34% |
Total Return Ranking - Trailing
| Period | BSGSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -5.9% | -20.2% | 18.8% | 97.97% |
| 1 Yr | -3.5% | -10.9% | 46.0% | 99.44% |
| 3 Yr | -7.2%* | -29.8% | 78.1% | 84.00% |
| 5 Yr | 7.5%* | -5.4% | 97.1% | 69.45% |
| 10 Yr | N/A* | -0.4% | 35.9% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | BSGSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 10.6% | -26.1% | 68.0% | 95.55% |
| 2022 | -27.3% | -67.0% | 440.7% | 45.15% |
| 2021 | 18.1% | -23.5% | 342.2% | 23.42% |
| 2020 | 43.9% | 2.6% | 2549.1% | 33.53% |
| 2019 | 36.7% | 14.6% | 44.8% | 30.88% |
NAV & Total Return History
BSGSX - Holdings
Concentration Analysis
| BSGSX | Category Low | Category High | BSGSX % Rank | |
|---|---|---|---|---|
| Net Assets | 177 M | 2.73 M | 100 B | 81.70% |
| Number of Holdings | 56 | 25 | 3644 | 76.89% |
| Net Assets in Top 10 | 47.8 M | 449 K | 9.69 B | 81.89% |
| Weighting of Top 10 | 27.08% | 0.4% | 99.9% | 49.35% |
Top 10 Holdings
- PTC Inc 3.20%
- First American Government Obligations Fund 3.15%
- RBC Bearings Inc 2.94%
- ICON PLC 2.78%
- Kadant Inc 2.77%
- Watsco Inc 2.62%
- Pool Corp 2.48%
- BWX Technologies Inc 2.46%
- Dynatrace Inc 2.42%
- Descartes Systems Group Inc/The 2.27%
Asset Allocation
| Weighting | Return Low | Return High | BSGSX % Rank | |
|---|---|---|---|---|
| Stocks | 95.91% | 0.92% | 101.30% | 88.17% |
| Cash | 4.09% | 0.00% | 99.08% | 16.45% |
| Preferred Stocks | 0.00% | 0.00% | 5.46% | 57.86% |
| Other | 0.00% | -0.18% | 16.96% | 65.80% |
| Convertible Bonds | 0.00% | 0.00% | 0.40% | 51.02% |
| Bonds | 0.00% | -3.27% | 1.87% | 53.79% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | BSGSX % Rank | |
|---|---|---|---|---|
| Technology | 30.15% | 0.04% | 62.17% | 60.26% |
| Healthcare | 25.60% | 0.00% | 37.06% | 8.69% |
| Industrials | 22.88% | 0.00% | 38.23% | 5.36% |
| Consumer Cyclical | 11.69% | 0.00% | 57.41% | 70.61% |
| Financial Services | 2.33% | 0.00% | 43.01% | 89.83% |
| Real Estate | 2.32% | 0.00% | 19.28% | 51.94% |
| Energy | 2.30% | 0.00% | 62.10% | 40.85% |
| Consumer Defense | 1.54% | 0.00% | 16.40% | 64.33% |
| Communication Services | 1.18% | 0.00% | 18.33% | 73.01% |
| Utilities | 0.00% | 0.00% | 12.94% | 63.03% |
| Basic Materials | 0.00% | 0.00% | 17.25% | 87.25% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | BSGSX % Rank | |
|---|---|---|---|---|
| US | 95.91% | 0.64% | 101.30% | 77.82% |
| Non US | 0.00% | 0.00% | 34.57% | 62.48% |
BSGSX - Expenses
Operational Fees
| BSGSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.23% | 0.02% | 17.54% | 37.55% |
| Management Fee | 0.75% | 0.00% | 1.50% | 56.85% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 45.85% |
| Administrative Fee | N/A | 0.00% | 0.40% | N/A |
Sales Fees
| BSGSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| BSGSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| BSGSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 50.00% | 0.00% | 250.31% | 59.96% |
BSGSX - Distributions
Dividend Yield Analysis
| BSGSX | Category Low | Category High | BSGSX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 35.39% | 60.26% |
Dividend Distribution Analysis
| BSGSX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | None | Annually | Annual | Annual |
Net Income Ratio Analysis
| BSGSX | Category Low | Category High | BSGSX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.88% | -2.24% | 2.75% | 73.92% |
Capital Gain Distribution Analysis
| BSGSX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
BSGSX - Fund Manager Analysis
Managers
Jonathan Good
Start Date
Tenure
Tenure Rank
Oct 31, 2018
3.58
3.6%
Jonathan joined Baird in 2006 and has 18 years of investment experience. He is currently the Portfolio Manager for the Small/Mid Cap Growth strategy and a Senior Research Analyst covering healthcare for the growth strategies. Before joining Baird Equity Asset Management, Jonathan worked at Gartmore Global Investments as an equity analyst for their Global Health Sciences Fund. Prior to joining Gartmore, he spent five years at William Blair & Company as an equity research associate covering Biotech, Lifesciences, Diagnostics and Orthopedics. Jonathan earned a degree in Applied and Biomedical Sciences from the University of Pennsylvania, and earned his MBA from the Kellogg School of Management at Northwestern University.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.04 | 36.3 | 9.34 | 11.76 |